Keywords
COVID-19, anti-CD20, rituximab, obinutuzumab, Omicron
Abstract
We describe four cases of COVID-19 infection during the Omicron wave, in patients treated with anti-CD20 monoclonal antibodies. All cases follow a similar biphasic clinical course consisting of respiratory deterioration, which occurred a few weeks after convalescence from initial mild to asymptomatic infection. Possible explanations are discussed.
References
Views: 581
HTML downloads: 194
PDF downloads: 291
Published:
2022-08-31
Issue:
2022: Vol 9 No 8
(view)